You are here: Industry Insights > SARS-CoV-2

News List

Targeting a new antibody supersite key to COVID immunity worldpharmanews
March 22, 2021
Scientists are learning that a lesser-studied region on the pandemic coronavirus is recognized by COVID-19 infection-fighting antibodies.
MRIGlobal Research Part Of First COVID-19 Test Approved For At-Home Use Without A Prescription prnewswire
March 22, 2021
MRIGlobal played a key role in achieving approval for the first SARS-CoV-2 diagnostic molecular test authorized for consumer at-home use without a prescription.
Leprosy drug holds promise as at-home treatment for COVID-19 worldpharmanews
March 19, 2021
A Nature study authored by scientists at Sanford Burnham Prebys Medical Discovery Institute and the University of Hong Kong, S.A.R., China shows that the leprosy drug clofazimine, which is FDA approved and on the World Health Organization's List of ...
BioVaxys Enters Agreement With Inotiv To Conduct Preclinical Toxicity Studies For Its Covid-T™ Immunodiagnostic Program prnewswire
March 19, 2021
BioVaxys Technology Corp., the world leader in haptenized protein vaccines for antiviral and cancer applications, announced that it has entered into an agreement with Bioanalytical Systems, Inc. d/b/a Inotiv, a global Contract Research Organization ...
Beckman Coulter Offers $4/High-throughput Antigen Test to Support U.S. Government Initiative to Expand COVID-19 Testing prnewswire
March 19, 2021
Beckman Coulter announced their commitment to support the U.S. government's plan to invest more than $12 billion to expand COVID-19 testing with their high-throughput, high-quality lab antigen test, Access SARS-CoV-2 Ag,* ideal for mass screening testing.
Codex DNA Releases Synthetic Genomes for Emerging SARS-CoV-2 Variants americanpharmaceuticalreview
March 18, 2021
Codex DNA announced the release of a full-length synthetic genomes for two emerging variants of the SARS-CoV-2 virus. The new genomes include the B.1.1.7 variant that initially emerged in the UK and the B.1351 variant that was first detected in ...
Tonix reports positive Covid-19 vaccine efficacy results in non-human primates dosed with TNX-1800 pharmaceutical-technology
March 18, 2021
Tonix Pharmaceuticals Holding has reported preliminary positive results after vaccination of non-human primates with TNX-1800, a live modified horsepox virus vaccine for percutaneous administration that is designed to express the Spike protein of ...
Fujifilm to launch rapid antigen COVID-19 test in Europe europeanpharmaceuticalreview
March 17, 2021
Having received the CE certificate, Fujifilm can now launch its highly-sensitive, rapid antigen test kit for SARS-CoV-2 in Europe.
Avacta’s Rapid Antigen Test Confirmed to Detect SARS-CoV-2 New Variants americanpharmaceuticalreview
March 16, 2021
Avacta has announced the AffiDX® SARS-CoV-2 rapid antigen lateral flow test detects the dominant new variants of the coronavirus, known as the B117, or ‘Kent’, variant, and the D614G variant, as well as the original strain.
Researchers reveal novel coronavirus jumped from bats to humans with ”very little change” expresspharma
March 16, 2021
However, some changes such as the D614G mutation, and similar tweaks in the virus spike protein has affected its biology.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 61 62 Next page